Join to View Full Profile
5323 Harry Hines BoulevardDallas, TX 75390
Phone+1 214-645-8765
Fax+1 214-645-8769
Dr. Meng is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Texas Southwestern Medical CenterFellowship, Minimally Invasive Urologic Surgery, 2019 - 2021
NYU Grossman School of MedicineResidency, Urology, 2015 - 2019- NYU Grossman School of MedicineInternship, Surgery, 2014 - 2015
- New York University School of MedicineClass of 2014
Certifications & Licensure
TX State Medical License 2019 - 2026
American Board of Urology Urology
Awards, Honors, & Recognition
- Inductee Alpha Omega Alpha Honor Medical Society
Clinical Trials
- Gemcitabine Versus Water Irrigation in Upper Tract Urothelial Carcinoma Start of enrollment: 2021 Nov 29
Publications & Presentations
PubMed
- Irreversible Electroporation for Prostate Tissue Ablation in Patients with Intermediate-risk Prostate Cancer: Results from the PRESERVE Trial.Arvin K George, Ranko Miocinovic, Amit R Patel, Derek J Lomas, Andres F Correa
European Urology. 2025-07-19 - The polarity protein Par3 enhances renal cell carcinoma metastasisYAP/TAZ activation.Soo Lee, Jonathan Balcazar, Karla Davis, Rey-Chen Pong, Jer-Tsong Hsieh
Cancer Biology & Medicine. 2025-07-08 - Prostate Ductal Adenocarcinoma Revisited: Clinicopathological and Genomic Characterization Identifies Heterogenous Group of Diseases with Implications for Patient Mana...Qi Cai, Xiaosong Meng, Jing Sun, Jeffrey Gagan, Aditi Aggarwal
Modern Pathology. 2025-06-01
Press Mentions
Children’s Research Institute at UT Southwestern Scientists Discover Kidney Cancers Rely on Mitochondrial Metabolism to MetastasizeAugust 14th, 2024- UT Southwestern Pioneers New Minimally Invasive Treatment for Prostate CancerDecember 8th, 2022
Anti-VEGF Fails to Boost Overall Survival in Bladder CancerNovember 21st, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
